VastCon
Winnipeg
About VastCon
VastCon Inc. is a biotech company developing early screening and diagnostics for cancer. VastCon was founded in 2011 by Drs. Anuraag Shrivastav and Shailly Varma Shrivastav and is headquartered in Winnipeg, Manitoba, Canada. The company includes a team of basic research scientists with the mandate to take research from the laboratory to bedside. VastCon’s lead product is a novel blood test for the early detection and screening of colorectal cancer. Colorectal cancer is the second or third leading cause of death due to cancer world-wide, despite being one of the most curable cancers if detected early. Unfortunately for many people, by the time it is detected it is already at an advanced stage leading to death.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $25.0K
- Funding stage: Seed
- Last round: Angel (Feb 2018)
- Website: vastcon.com
- Phone: (204)416-8256
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/vastcon-2211110 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.